Since the start of the COVID-19 pandemic, many diagnostics have been authorized by the US FDA. While these tend to highlight the benefits an authorized company sees in the approval of a new test, they can be difficult to parse.

Rodney E. Rohde, a clinical laboratory specialist at Texas State University, helps break down how they work.

свернуть